Innovative Paper-Based Device Successfully Detects Malaria in Asymptomatic Individuals During Field Testing

A new paper-based diagnostic device has demonstrated high accuracy in detecting asymptomatic malaria infections in field tests in Ghana, outperforming traditional methods and offering a portable, rapid alternative for malaria control efforts.
Recent advancements in diagnostic technology have led to the development of low-cost, paper-based devices capable of identifying malaria infections even in individuals showing no symptoms. In a study conducted in Ghana, these paper strips outperformed traditional testing methods, such as microscopy, rapid diagnostic tests, and PCR, by detecting a higher number of positive cases. The innovative device relies on simple chemical reactions within layered paper structures, which interact with blood samples to reveal the presence of malaria antigens through a mass spectrometry analysis.
Led by Professor Abraham Badu-Tawiah from The Ohio State University, the research demonstrates that the device achieves approximately 90% accuracy, comparable to the benchmark PCR tests. Its portability, stability, and quick turnaround make it especially valuable for remote and resource-limited regions where standard laboratory facilities are unavailable. The test results are available within 30 minutes, and the devices can be stored indefinitely without refrigeration, facilitating widespread deployment.
During field trials involving 266 volunteers, the paper-based test identified 184 positive cases—significantly more than microscopy (24 cases), rapid tests (63 cases), and even PCR (142 cases). These findings highlight the limitations of traditional diagnostic methods in detecting low parasite densities typical of asymptomatic infections. The high sensitivity of the paper device points to its potential as a powerful tool in malaria elimination efforts.
Since first proposing this technology in 2016, Badu-Tawiah’s team has refined the manufacturing process, which involves manually assembling multiple layers of treated paper coated with wax to prevent blood seepage. Blood samples introduced into the device undergo chemical reactions, leading to the formation of detectable compounds tagged for analysis. After a brief washing, the strips are analyzed by a portable mass spectrometer to confirm the presence of malaria antigens.
The innovation facilitates not only rapid diagnosis but also easy storage and transportation, bypassing the need for complex cold-chain logistics. The implications extend beyond malaria, with ongoing research into adapting the device for detecting other diseases such as colorectal cancer and pancreatitis. The team is also engaging with the Ghanaian government to implement large-scale screening programs, aiming to significantly improve malaria detection and control in endemic regions.
Overall, this paper-based diagnostic approach represents a promising step towards more accessible and effective disease management in some of the world's most challenging environments.
Source: https://medicalxpress.com/news/2025-06-paper-based-devices-malaria-asymptomatic.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Impact of Republican Medicaid Reductions on Rural Hospitals
Proposed Medicaid funding cuts by House Republicans could lead to widespread closures of rural hospitals and threaten essential healthcare services for vulnerable populations across the U.S.
Innovative Use of IntelliCage to Study Spontaneous Behaviors in Schizophrenia Mouse Models
A novel study demonstrates how the IntelliCage system enables long-term, naturalistic monitoring of spontaneous behaviors in mouse models of schizophrenia, advancing psychiatric research and therapy development.
End of Measles Outbreaks in Illinois and North Dakota
Health authorities have declared the end of measles outbreaks in Illinois and North Dakota amid a nationwide decline in cases and ongoing outbreaks in other regions. Vaccination remains the best prevention.
Promising Results for GLP-1 Receptor Agonists in Reducing Chronic Migraine Frequency
A pilot study reveals that GLP-1 receptor agonists, such as liraglutide, may significantly reduce the frequency of chronic migraines, offering new hope for treatment-resistant patients.